Glycomics/Glycobiology Market | Major Key Players Include Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan)

Glycomics products are widely used for the analysis of cell surface markers, which can act as diagnostic or therapeutic targets. Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of the market.

The global glycobiology market is poised to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%.

Glycomics is a promising approach to biomarker discovery and validation. The development of various separation techniques coupled with the advanced structure determination capabilities of this field makes possible the separation and identification of thousands of glycans from complex mixtures. Biomarker identification presents significant opportunities for the glycomics market. Glycomics also has a wide range of applications in drug development and enhancement. Glycomics products such as enzymes, kits, and reagents are often used in investigating the role of sugars in the development and progression of diseases like cancer, Alzheimer’s, Parkinson’s, and various infectious diseases like herpes and AIDS.

On the basis of region, the market is segmented into North America, Asia, Europe, and RoW. The Asian market is estimated to grow at the highest CAGR during the forecast period. This growth is mainly attributed to the increasing commercialization of R&D by pharmaceutical and biotechnology companies, growing demand for personalized medicine, and rising importance of companion diagnostics.

Get Free Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525

The key players in the glycobiology market include Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).

Share this post:

Related Posts

Comments are closed.